{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:18:25Z","timestamp":1773148705292,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of the American Dental Association"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.14219\/jada.archive.2005.0109","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T23:36:58Z","timestamp":1389224218000},"page":"1669-1674","source":"Crossref","is-referenced-by-count":65,"title":["Bisphosphonate-associated osteonecrosis of the jaws"],"prefix":"10.1016","volume":"136","author":[{"given":"MICHAEL R.","family":"MARKIEWICZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"JOSEPH E.","family":"MARGARONE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHN H.","family":"CAMPBELL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALFREDO","family":"AGUIRRE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14219\/jada.archive.2005.0109_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.leu.2400892","article-title":"In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates","volume":"12","author":"Aparicio","year":"1998","journal-title":"Leukemia"},{"issue":"supplement 2","key":"10.14219\/jada.archive.2005.0109_bib2","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.3816\/CBC.2005.s.005","article-title":"Evolving role of bisphosphonates in women undergoing treatment for localized and advanced breast cancer","volume":"5","author":"Gralow","year":"2005","journal-title":"Clin Breast Cancer"},{"key":"10.14219\/jada.archive.2005.0109_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1470-2045(03)01077-5","article-title":"Management of multiple myeloma: a systematic review and critical appraisal of published studies","volume":"4","author":"Kumar","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.14219\/jada.archive.2005.0109_bib4","first-page":"2602","article-title":"Bisphosphonate treatment inhibits the growth of prostate cancer cells","volume":"61","author":"Lee","year":"2001","journal-title":"Cancer Res"},{"key":"10.14219\/jada.archive.2005.0109_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00223-002-0025-x","article-title":"Bisphosphonate actions on cancer","volume":"73","author":"Yoneda","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"10.14219\/jada.archive.2005.0109_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00063030-200418040-00004","article-title":"Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities","volume":"18","author":"Santini","year":"2004","journal-title":"BioDrugs"},{"key":"10.14219\/jada.archive.2005.0109_bib7","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.joms.2003.09.001","article-title":"Avascular necrosis of the jaws: risk factors in metastatic cancer patients","volume":"61","author":"Tarassoff","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.14219\/jada.archive.2005.0109_bib8","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.14219\/jada.archive.2005.0109_bib9","first-page":"268","article-title":"Bisphosphonates and avascular necrosis of the jaws","volume":"48","author":"Carter","year":"2003","journal-title":"Aust Dent J"},{"key":"10.14219\/jada.archive.2005.0109_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.14219\/jada.archive.2005.0109_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/hed.2890040313","article-title":"Osteonecrosis of the jaws: a complication of cancer chemotherapy","volume":"4","author":"Schwartz","year":"1982","journal-title":"Head Neck Surg"},{"key":"10.14219\/jada.archive.2005.0109_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tripleo.2004.08.001","article-title":"Intravenous bisphosphonates and osteonecrosis","volume":"98","author":"Greenberg","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"4","key":"10.14219\/jada.archive.2005.0109_bib13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1754-4505.2002.tb01178.x","article-title":"Osteonecrosis of the maxilla as a complication to chemotherapy: a case report","volume":"22","author":"Sung","year":"2002","journal-title":"Spec Care Dentist"},{"issue":"2","key":"10.14219\/jada.archive.2005.0109_bib14","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo","year":"2005","journal-title":"J Can Dent Assoc"},{"key":"10.14219\/jada.archive.2005.0109_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.14219\/jada.archive.2005.0109_bib16","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"10.14219\/jada.archive.2005.0109_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases","volume":"34","author":"Bagan","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"10.14219\/jada.archive.2005.0109_bib19","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1200\/JCO.1998.16.12.3890","article-title":"Current use of bisphosphonates in oncology: International Bone and Cancer Study Group","volume":"16","author":"Body","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.14219\/jada.archive.2005.0109_bib20","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.14219\/jada.archive.2005.0109_bib21","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow","volume":"83","author":"Hughes","year":"1989","journal-title":"J Clin Invest"},{"issue":"1","key":"10.14219\/jada.archive.2005.0109_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jbmr.5650050107","article-title":"Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy","volume":"5","author":"Sato","year":"1990","journal-title":"J Bone Miner Res"},{"key":"10.14219\/jada.archive.2005.0109_bib23","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1182\/blood.V96.12.4006","article-title":"Inhibition of matrix metalloproteinases by bisphosphonates may in part explain their effects in the treatment of multiple myeloma","volume":"96","author":"Teronen","year":"2000","journal-title":"Blood"},{"key":"10.14219\/jada.archive.2005.0109_bib24","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1210\/endo.137.6.8641182","article-title":"Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption","volume":"137","author":"Vitte","year":"1996","journal-title":"Endocrinology"},{"key":"10.14219\/jada.archive.2005.0109_bib25","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenetic factors in cancer patients","volume":"8","author":"Santini","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.14219\/jada.archive.2005.0109_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.14219\/jada.archive.2005.0109_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?","volume":"63","author":"Hellstein","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.14219\/jada.archive.2005.0109_bib28","first-page":"18","article-title":"Pharmacokinetics of alendronate: an overview","volume":"101","author":"Lin","year":"1999","journal-title":"Int J Clin Pract Suppl"}],"container-title":["The Journal of the American Dental Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817714624466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817714624466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T17:15:07Z","timestamp":1597338907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002817714624466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0002817714624466"],"URL":"https:\/\/doi.org\/10.14219\/jada.archive.2005.0109","relation":{},"ISSN":["0002-8177"],"issn-type":[{"value":"0002-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}